EGFR and neoplasm: Furthermore, systemic delivery of the nanoparticles carrying the siRNAs to suppress the expression of ER/BCL-2 and ER/ERBB2/EGFR groups of proteins resulted in a notable and sustainable decrease in tumor growth in a 4T1-induced syngeneic mouse model.